Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07131956) titled 'Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy' on Aug. 3.
Study Type: Observational
Primary Sponsor: University of Erlangen-Nurnberg Medical School
Condition:
Prostate Cancer (Diagnosis)
Prostate Cancer Patients Who Have Brachytherapy Seed Implant
Prostate Cancer Patients Treated by Radiotherapy
Prostate Cancer Recurrent
Recruitment Status: Recruiting
Date of First Enrollment: August 2025
Target Sample Size: 200
Countries of Recruitment:
Germany
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07131956
Published by HT Digital Content Services with permission from Health...